The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28.
about
Metastatic disease from uveal melanoma: treatment options and future prospectsDelayed systemic recurrence of uveal melanomaUveal melanoma: epidemiology, etiology, and treatment of primary disease.Clinical Performance and Management Outcomes with the DecisionDx-UM Gene Expression Profile Test in a Prospective Multicenter Study.Surgery of primary melanomas.Management of uveal melanoma: a consensus-based provincial clinical practice guidelineEfficacy of curcumin in inducing apoptosis and inhibiting the expression of VEGF in human pterygium fibroblastsBimodal mortality dynamics for uveal melanoma: a cue for metastasis development traits?INTERACTS (INTErventional Radiotherapy ACtive Teaching School) guidelines for quality assurance in choroidal melanoma interventional radiotherapy (brachytherapy) procedures.Does ocular treatment of uveal melanoma influence survival?Curcumin induces cell death in human uveal melanoma cells through mitochondrial pathway.Irreversible electroporation of human primary uveal melanoma in enucleated eyes.Comparison of dose calculation methods for brachytherapy of intraocular tumors.Ocular melanoma: an overview of the current status.Current and emerging treatment options for uveal melanoma.Local treatment failure after globe-conserving therapy for choroidal melanoma.Assessment of the effect of iris colour and having children on 5-year risk of death after diagnosis of uveal melanoma: a follow-up study.Unilateral temporal haemianopia in a patient with non-small cell lung cancer: intraocular metastasis despite chemotherapy.Uveal melanoma: estimating prognosis.I-125 brachytherapy for choroidal melanoma photographic and angiographic abnormalities: the Collaborative Ocular Melanoma Study: COMS Report No. 30.Cost-effectiveness of proton beam therapy for intraocular melanoma.Incidence and indications for pars plana vitrectomy following the treatment of posterior uveal melanomas in Scotland.iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma TumorsDetection of circulating melanoma cells in choroidal melanocytic lesions.Clinical Characteristics of 582 Patients with Uveal Melanoma in China.Choroidal melanomaVisual Acuity, Contrast Sensitivity and Color Vision Three Years After Iodine-125 Brachytherapy for Choroidal and Ciliary Body MelanomaEpiscleral plaque brachytherapy using 'BARC I-125 Ocu-Prosta seeds' in the treatment of intraocular tumors: a single-institution experience in India(106)Ru plaque brachytherapy for uveal melanoma: factors associated with local tumor recurrence.Combinations of radiation therapy and immunotherapy for melanoma: a review of clinical outcomesIntravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachmentMicroincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanomaRuthenium-106 brachytherapy for thick uveal melanoma: reappraisal of apex and base dose radiation and dose ratePrognostic factors of choroidal melanoma in Slovenia, 1986-2008.Comparison of survival among eligible patients not enrolled versus enrolled in the Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma.Uveal melanoma in the Saudi Arabian population: Two decades of management at the King Khaled Eye Specialist Hospital.Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.A first report of radioembolization for hepatic metastases from ocular melanoma.Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes.Collaborative ocular melanoma study randomized trial of I-125 brachytherapy.
P2860
Q26738377-C06E103C-7696-4DCA-A35D-851849B762DEQ28268997-9DD42396-2029-4651-9461-C77622465746Q30235934-F0212DEF-174A-442D-B81C-FC7EBF604D95Q30276302-B5BD34B5-1DE9-4FB4-9796-B16B895ECE0BQ30356095-A4107273-3D10-4E69-B679-4E9113BCACDFQ30388575-2F56153F-2D77-487D-B536-8C8F39122D5AQ33598302-8C3FEF02-603A-468C-B8B9-9B1E4973C456Q33719777-C31CB912-1ACA-405F-957C-9091952EF6B8Q33903591-FFB184C1-6E3C-48D5-9C7F-9CBB1A1B235BQ34059687-41CEB1B1-2C3D-4093-AF25-A9FFC62409DBQ34108933-F5E2E2C5-34A2-44C6-A8D8-975DDDEA17E1Q34371472-82AA73D1-D67E-45DE-AFD8-19BA7ADB6C1FQ34493736-60E58836-004A-494D-83CD-EE77C2846A5DQ34653896-40ED5F23-34E0-47D8-B81F-D82860E96E59Q34655878-447F9DAC-5789-4A4E-85D1-F9A85FC12A19Q34706558-DF6A92B9-58E2-4F20-8325-21196F0913B1Q35135787-B0DD2BE0-769A-4E88-9AF6-B1360B61CAA9Q35145269-9D6391B7-C8EC-4905-A13B-BA1D944DC8B5Q35440546-F4AC560A-8821-4CAB-8654-A4DA4B3E1AA2Q35460719-3E05DCC4-9BD3-4ADF-A7C2-FE0EE3C91453Q35620609-645E2464-A914-4A44-A435-7212D4ED51AEQ35748947-CDDFF110-4BC3-48CB-9AA3-7A6D2172E5E0Q35754900-51BC697F-DEB3-429D-928A-E2F8FEC83CDFQ35780352-C493FCF8-2936-4536-BD16-A6B193C08FD3Q35863197-0500D74A-3A5B-44CB-AEE9-4A2CA925DEFFQ35920809-D7F4C3E9-AAEA-42C1-AAF1-89A9CB7BA8E5Q35969886-1905544B-DFC2-47C5-8870-0CEFA310B8CEQ36234605-4D7E4205-8494-4963-9FC2-1DA458142BFAQ36331200-AB3D0F79-D666-4E27-9B9C-2C3B4036EAFFQ36340598-A265DDEB-36B7-406D-BFEF-944447C99EBBQ36568032-8868F22F-6E71-4F9A-B4EC-776795405BD7Q36659131-094B621C-40D1-4B1F-9E63-6C8CAE4E4A7CQ36690535-24E398D0-D03C-4EC7-BE14-CDF3E1194537Q36779868-70870FCE-C60E-420F-AD24-C6CDAB3D3A17Q36951815-0B7CB85E-ADF5-4035-A4A9-E975A91E6A1DQ37059951-21005E21-15B2-42AB-B552-86AC7C69A3C3Q37188699-8058A0F2-4D89-427D-88DE-2D47545052FBQ37393973-F67D60F2-9A40-44E3-B650-2460767A5A46Q37705141-4D1EFD8B-F188-4BFA-9E37-497EDC92A9B2Q37947556-C294F4F3-EC16-4DFD-83BD-DB2C21C47B44
P2860
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The COMS randomized trial of i ...... c factors: COMS report No. 28.
@en
The COMS randomized trial of i ...... c factors: COMS report No. 28.
@nl
type
label
The COMS randomized trial of i ...... c factors: COMS report No. 28.
@en
The COMS randomized trial of i ...... c factors: COMS report No. 28.
@nl
prefLabel
The COMS randomized trial of i ...... c factors: COMS report No. 28.
@en
The COMS randomized trial of i ...... c factors: COMS report No. 28.
@nl
P1433
P1476
The COMS randomized trial of i ...... c factors: COMS report No. 28.
@en
P2093
Collaborative Ocular Melanoma Study Group
P304
P356
10.1001/ARCHOPHT.124.12.1684
P407
P577
2006-12-01T00:00:00Z